Skip to main content

Junius Daniel M

In the past year, 1 open-market sale filing worth $844.9K and no purchases.

Current role at each company

  • IDXXIDEXX Laboratories IncDirectoras of Nov 5, 2026
  • CBIOCrescent Biopharma, Inc.Directoras of May 1, 2024

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
$844.9K
1 filing
Net
−$844.9K
Bought minus sold
Companies
1
With open-market trades

Trades

Every Form 4 that lists Junius Daniel M as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

IDXX IDEXX Laboratories Inc

Director5 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 12, 2021 (view filing)Aug 102 daysJunius Daniel MDirectorSSale−2.40K$679.58−$1.63M−45.3%2.90K after
Dec 7, 2022 (view filing)Dec 52 daysJunius Daniel MDirectorSSale−3.05K$424.91−$1.29M−50.6%2.97K after
Feb 17, 2023 (view filing)Feb 161 dayJunius Daniel MDirectorSSale−2.19K$511.68−$1.12M−42.3%2.98K after
May 14, 2025 (view filing)May 131 dayJunius Daniel MDirectorSSale−2.68K$506.41−$1.36M−44.8%3.30K after
Nov 5, 2026 (view filing)5:01 PM ETNov 41 dayJunius Daniel MDirectorSSale−1.20K$704.07−$844.9K−33.7%2.36K after2 lots

CBIO Crescent Biopharma, Inc.

Director2 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Nov 18, 2022 (view filing)Nov 171 dayJunius Daniel MDirectorPPurchase+20.0K$1.87+$37.4K+46.2%63.3K after
May 11, 2023 (view filing)May 101 dayJunius Daniel MDirectorPPurchase+30.0K$1.56+$46.8K+47.4%93.3K after